The treatment could hold real promise as coronavirus infections and deaths outside of China continue to swell. “There is only one drug right now that we think may have real efficacy and that’s remdesivir,” said WHO assistant director-general Bruce Aylward during a press conference in Beijing on Monday. The drug is already being enlisted in clinical trials in China.
Gilead’s antiviral remdesivir is being used in the first U.S. clinical trial to treat COVID-19, the disease caused by the new coronavirus.
Comments are closed.